> Sirion Therapeutics has completed a merger with Sytera, a La Jolla, CA-based biopharmaceutical firm working on new treatments for dry AMD. Release
> BioMS has won the approval of its data monitoring committee to continue its pivotal study of MBP8298 for the treatment of secondary progressive multiple sclerosis. Release
> Evotec has won its second €1 million milestone in its collaboration with Takeda Pharmaceuticals. Report
> Algeta and Affibody, which are building a pipeline of products based on tumor-targeting affinity molecules, today announced a research collaboration agreement to develop novel targeted radiotherapeutics. Release
> India's Strides Arcolab has inked a deal with Gilead Sciences to distribute generic versions of Truvada and Viread. Report
> A new report says that the FDA's drug directory is woefully outdated. Report
> Switzerland's Speedel has retained all commercialization rights to the blood clotting drug SPP200, citing positive data. Report
And Finally… Don't put down that cup of java. Four to six cups of coffee a day can be a healthful tonic for most people, say researchers. Article